ERBB2 and breast carcinoma: SM significantly reduced the number of HER2/neu receptors on the cell membrane of the breast cancer cell line (ZR‐75‐1 cells) and enhanced the sensitivity of breast cancer cells to chemotherapeutic drugs.116